Click on the session name for more details about the session

Friday, March 10, 2023

TimePlenary Hall
10:00 AM - 10:25 AM Industry Symposium by Novo NordiskRefixia®: A State of the Art, Extended Half-Life rFIX for the Management of Haemophilia B

Industry Symposium by Novo Nordisk

Friday, March 10, 2023 at 10:00 AM - 10:25 AM on

Topics :

Refixia®: A State of the Art, Extended Half-Life rFIX for the Management of Haemophilia B
Mohammad Fahed Abdullah
United Arab Emirates
10:00 AM - 10:25 AM

Close

x
10:25 AM - 10:50 AM Industry Symposium by BMSIneffective erythropoiesis as a driver for chronic anemias

Industry Symposium by BMS

Friday, March 10, 2023 at 10:25 AM - 10:50 AM on

Topics :

Ineffective erythropoiesis as a driver for chronic anemias
Amar Lal
United Arab Emirates
10:25 AM - 10:50 AM

Close

x
10:50 AM - 11:15 AM Industry Symposium by EmmausSickle Cell Disease Management Updates

Industry Symposium by Emmaus

Friday, March 10, 2023 at 10:50 AM - 11:15 AM on

Chairperson :

Mahmoud Marashi
United Arab Emirates

Topics :

Sickle Cell Disease Management Updates
Sultan Almutairi
Saudi Arabia
10:50 AM - 11:15 AM

Close

x
11:15 AM - 11:40 AM Industry Symposium by CSL ViforHow to create an Ironwoman: Real world issues in Iron Deficiency Anemia

Industry Symposium by CSL Vifor

Friday, March 10, 2023 at 11:15 AM - 11:40 AM on

Topics :

How to create an Ironwoman: Real world issues in Iron Deficiency Anemia
Shahrukh Hashmi
United Arab Emirates
11:15 AM - 11:40 AM

Close

x
11:40 AM - 12:05 PM Industry Symposium by by AstellasBe Ready for R/R AML FLT3 m+ (View from A Clinic)

Industry Symposium by by Astellas

Friday, March 10, 2023 at 11:40 AM - 12:05 PM on

Topics :

Be Ready for R/R AML FLT3 m+ (View from A Clinic)
Mahmoud Marashi
United Arab Emirates
11:40 AM - 12:05 PM

Close

x
12:05 PM - 01:45 PM Lunch Break & Friday Prayer
01:45 PM - 02:05 PM Industry Symposium by TakedaOverview of SID: Approaches to Diagnosing and Managing Secondary Immunodeficiency

Industry Symposium by Takeda

Friday, March 10, 2023 at 01:45 PM - 02:05 PM on

Topics :

Overview of SID: Approaches to Diagnosing and Managing Secondary Immunodeficiency
Ravi Gutta
United Arab Emirates
01:45 PM - 02:05 PM

Close

x
02:05 PM - 02:30 PM Industry Symposium by SandozRixathon ( Rituxmab by Sandoz) Totality of evidence: from Concept to Reality

Industry Symposium by Sandoz

Friday, March 10, 2023 at 02:05 PM - 02:30 PM on

Chairperson :

Mahmoud Marashi
United Arab Emirates

Topics :

Rixathon ( Rituxmab by Sandoz) Totality of evidence: from Concept to Reality
Faraz Khan
United Arab Emirates
02:05 PM - 02:30 PM

Close

x
02:30 PM - 03:00 PM Industry Symposium by JanssenA New Era of Treatment Freedom in CLL

Industry Symposium by Janssen

Friday, March 10, 2023 at 02:30 PM - 03:00 PM on

Chairperson :

Hani Osman
United Arab Emirates

Topics :

A New Era of Treatment Freedom in CLL
Othman Al-Sawaf
United Kingdom
02:30 PM - 03:00 PM

Close

x
03:00 PM - 03:10 PM Coffee Break 1
03:10 PM - 03:30 PM Opening Ceremony
03:30 PM - 05:05 PM Session 1: Hemostasis & Thrombosis

Session 1: Hemostasis & Thrombosis

Friday, March 10, 2023 at 03:30 PM - 05:05 PM on

Chairperson :

Salam Al Kindi
Oman
Amna Al Mehairi
United Arab Emirates

Topics :

Managing competing risks of thrombosis, bleeding and anticoagulation in patients with malignancy
Hanny Al- Samkari
United States
03:30 PM - 03:50 PM
Hypercoagulable states and Thrombosis
Stephan Moll
United States
03:50 PM - 04:10 PM
ITP: Pathophysiology and Management
Hanny Al- Samkari
United States
04:10 PM - 04:30 PM
Unexplained arterial thrombosis
Stephan Moll
United States
04:30 PM - 04:50 PM
Q&A - Meet the Experts (S1)
Q&A - Meet the Experts
04:50 PM - 05:05 PM

Close

x
05:05 PM - 05:30 PM Industry Symposium by AmgenNovel approaches in MM

Industry Symposium by Amgen

Friday, March 10, 2023 at 05:05 PM - 05:30 PM on

Topics :

Novel approaches in MM
Amar Lal
United Arab Emirates
05:05 PM - 05:30 PM

Close

x
05:30 PM - 06:40 PM Session 2: Nursing WorkshopUpdates in the Management of Hematological disorders

Session 2: Nursing Workshop

Friday, March 10, 2023 at 05:30 PM - 06:40 PM on

Chairperson :

Khaled Al Qawasmeh
United Arab Emirates
Amal Al Haddad
United Arab Emirates

Topics :

CAR T Cell
Mahmoud Hasan
United Arab Emirates
05:30 PM - 05:45 PM
Cancer Genetics, Latest Research and Reviews
Amal Al Haddad
United Arab Emirates
05:45 PM - 06:00 PM
Chronic lymphocytic leukemia: 2022 update on therapeutic procedures
Khaled Al Qawasmeh
United Arab Emirates
06:00 PM - 06:15 PM
New Management of hemophilia A patients (Gene Therapy)
Manal Rayyan
United Arab Emirates
06:15 PM - 06:30 PM
Q&A and Panel Discussion
Q&A and Panel Discussion
06:30 PM - 06:40 PM

Close

x
06:40 PM - 07:05 PM Industry Symposium by RocheDLBCL 2023: Where do we stand?

Industry Symposium by Roche

Friday, March 10, 2023 at 06:40 PM - 07:05 PM on

Chairperson :

Hani Osman
United Arab Emirates

Topics :

DLBCL 2023: Where do we stand?
Andrew Davies
United Kingdom
06:40 PM - 07:05 PM

Close

x

Saturday, March 11, 2023

TimePlenary Hall
08:30 AM - 09:30 AM Session 3: Abstracts Session

Session 3: Abstracts Session

Saturday, March 11, 2023 at 08:30 AM - 09:30 AM on

Chairperson :

Khawla M. Belhoul
United Arab Emirates
Sherian Salama
United Arab Emirates

Topics :

Growth and endocrinopathies among children with β-thalassemia major treated at Dubai thalassemia centre
Rabah Almahmoud
United Arab Emirates
08:30 AM - 08:35 AM
Q&A
Q&A
08:35 AM - 08:37 AM
An unusual presentation of metastatic breast cancer with microangiopathic hemolytic anemia and thrombocytopenia.
Saubia Fathima
United Arab Emirates
08:37 AM - 08:42 AM
Q&A
Q&A
08:42 AM - 08:44 AM
Tissue Factor Pathway Inhibitor and Tissue Factor Pathway Inhibitor-rs7586970 variant in Myocardial Infarction with Type 2 Diabetes Mellitus
Doha Abdel Hamid
Egypt
08:44 AM - 08:49 AM
Q&A
Q&A
08:49 AM - 08:51 AM
Incidence of Blood transfusion reactions over 10 years and the prevalence of alloantibodies at Dubai Thalassemia Center
Fatheya Al Khaja
United Arab Emirates
08:51 AM - 08:56 AM
Q&A
Q&A
08:56 AM - 08:58 AM
United Arab Emirates Population-Based Acute Leukaemia Registry: Acute Lymphoblastic Leukaemia Real-World Data
Waed Jaber
United Arab Emirates
08:58 AM - 09:03 AM
Q&A
Q&A
09:03 AM - 09:05 AM
Hypomethylating agent (HMA) and venetoclaxR as salvage therapy for Acute Myeloid Leukaemia (AML) failing intensive induction therapy. A single centre experience from United Arab Emirates
Amar Lal
United Arab Emirates
09:05 AM - 09:10 AM
Q&A
Q&A
09:10 AM - 09:12 AM
Expression levels of JAK/STAT signaling proteins in newly diagnosed and in remission in patients with acute myeloid leukemia
Safa Alamrani
Oman
09:12 AM - 09:17 AM
Q&A
Q&A
09:17 AM - 09:19 AM
Comparison of the clinical features and outcome of children with hemophagocytic lymphohistiocytosis (HLH) secondary to visceral leishmaniasis and primary HLH
Mahdi Shahriari
Iran
09:19 AM - 09:24 AM
Q&A
Q&A
09:24 AM - 09:30 AM

Close

x
09:30 AM - 11:00 AM Session 4: Myeloma

Session 4: Myeloma

Saturday, March 11, 2023 at 09:30 AM - 11:00 AM on

Chairperson :

Inas El Najjar
United Arab Emirates
Mustaqeem Siddiqui
United Arab Emirates

Topics :

Myeloma management in 2023, what’s the best approach?
Brian Durie
United States
09:30 AM - 09:50 AM
Can Myeloma be cured?
Noopur Raje
United States
09:50 AM - 10:10 AM
MGUS, how benign is it?
Brian Durie
United States
10:10 AM - 10:30 AM
Molecular target in myeloma
Noopur Raje
United States
10:30 AM - 10:50 AM
Q&A - Meet the Experts (S4)
Q&A - Meet the Experts
10:50 AM - 11:00 AM

Close

x
11:00 AM - 11:15 AM Coffee Break 2
11:15 AM - 12:05 PM Session 5: Survivorship

Session 5: Survivorship

Saturday, March 11, 2023 at 11:15 AM - 12:05 PM on

Chairperson :

Amar Lal
United Arab Emirates

Topics :

Dr I’m now 5 years post therapy for Hodgkin Lymphoma and I’m likely cured.  What would be next?
Chandley Silin
United States
11:15 AM - 11:40 AM
Integrating survivorship care into oncology practice: Challenges and Opportunities?
Chandley Silin
United States
11:40 AM - 12:05 PM

Close

x
12:05 PM - 12:30 PM Industry Symposium by LillyIndolent lymphoproliferative disease

Industry Symposium by Lilly

Saturday, March 11, 2023 at 12:05 PM - 12:30 PM on

Topics :

Indolent lymphoproliferative disease
Toby A. Eyre
United Kingdom
12:05 PM - 12:30 PM

Close

x
12:30 PM - 02:00 PM Session 6: Lymphoproliferative disorders (I)

Session 6: Lymphoproliferative disorders (I)

Saturday, March 11, 2023 at 12:30 PM - 02:00 PM on

Chairperson :

Faraz Khan
United Arab Emirates
Rania Medhat Seliem
United Arab Emirates

Topics :

WHO update in lymphoma
Robert Hasserjian
United States
12:30 PM - 12:50 PM
How I treat Follicular lymphoma in 2023
Laurie Sehn
Canada
12:50 PM - 01:10 PM
Should all aggressive B- cell lymphoma be managed the same?
Jeremy Abramson
United States
01:10 PM - 01:30 PM
Management of indolent lymphomas, is targeting therapy way to go?
Laurie Sehn
Canada
01:30 PM - 01:50 PM
Q&A - Meet the Experts (S6)
Q&A - Meet the Experts
01:50 PM - 02:00 PM

Close

x
02:00 PM - 02:50 PM Lunch Break 2
02:50 PM - 03:15 PM Industry Symposium by AbbvieUnmet Needs in RR DLBCL

Industry Symposium by Abbvie

Saturday, March 11, 2023 at 02:50 PM - 03:15 PM on

Topics :

Unmet Needs in RR DLBCL
Laurie Sehn
Canada
02:50 PM - 03:15 PM

Close

x
03:15 PM - 05:40 PM Session 7: Lymphoproliferative disorders (II)

Session 7: Lymphoproliferative disorders (II)

Saturday, March 11, 2023 at 03:15 PM - 05:40 PM on

Chairperson :

Arif Alam
United Arab Emirates
Ali Bazarbachi
Lebanon
Kayane Mheidly
United Arab Emirates

Topics :

How I treat Relapsed/Refractory Classic Hodgkin lymphoma in young & frail?
Ranjana Advani
United States
03:15 PM - 03:35 PM
How I treat T Cell lymphoma in 2023
Jasmine Zain
United States
03:35 PM - 03:55 PM
Should everyone with relapsed/ refractory lymphoma go to CAR T cell therapy?
Jeremy Abramson
United States
03:55 PM - 04:15 PM
Evaluation & management of cutaneous T cell lymphoma
Jasmine Zain
United States
04:15 PM - 04:35 PM
Best of ASH in lymphoma
Ranjana Advani
United States
04:35 PM - 05:20 PM
Q&A - Meet the Experts (S7)
Q&A - Meet the Experts
05:20 PM - 05:40 PM

Close

x
05:40 PM - 05:55 PM Session 8High Dose Methotrexate Toxicity Management

Session 8

Saturday, March 11, 2023 at 05:40 PM - 05:55 PM on

Chairperson :

Husni Al Hateeti
United Arab Emirates

Topics :

High Dose Methotrexate Toxicity Management
Faraz Khan
United Arab Emirates
05:40 PM - 05:55 PM

Close

x
05:55 PM - 06:20 PM Perspectives in Haemophilia A management: recent results from Efanesoctocog alfa trialsUpdates in Hemphilia A management: recent clinical data from Efanesoctocog alfa

Perspectives in Haemophilia A management: recent results from Efanesoctocog alfa trials

Saturday, March 11, 2023 at 05:55 PM - 06:20 PM on

Chairperson :

Muhammad Faisal Khanani
United Arab Emirates
Hani Osman
United Arab Emirates

Topics :

Perspectives in Haemophilia A management: recent results from Efanesoctocog alfa trials
Elena Santagostino
05:55 PM - 06:20 PM

Close

x

Sunday, March 12, 2023

TimePlenary HallWorkshop Room
08:30 AM - 09:45 AM Session 9: Leukemias (I)

Session 9: Leukemias (I)

Sunday, March 12, 2023 at 08:30 AM - 09:45 AM on

Chairperson :

Mohamed Abuhaleeqa
United Arab Emirates
Murtadha Al-Khabori
Oman

Topics :

WHO updates in Myeloid neoplasm
Robert Hasserjian
United States
08:30 AM - 08:50 AM
How I treat Blastic Plasmacytoid Dendretic Cell Neoplasm (BPDCN)
Naveen Pemmaraju
United States
08:50 AM - 09:10 AM
Evolution & Management of ALL
Robin Foà
Italy
09:10 AM - 09:30 AM
Q&A - Meet the Experts (S9)
Q&A - Meet the Experts
09:30 AM - 09:45 AM

Close

x

Thursday, January 01, 1970 at 12:00 AM - 12:00 AM on

Close

x
09:45 AM - 10:00 AM Coffee Break 3
10:00 AM - 11:15 AM Session 10: Leukemias (II)

Session 10: Leukemias (II)

Sunday, March 12, 2023 at 10:00 AM - 11:15 AM on

Chairperson :

Julieta Zuluaga
United Arab Emirates
Ahmad Alhuraiji
Kuwait

Topics :

Using precision medicine to treat AML in 2023
Naveen Pemmaraju
United States
10:00 AM - 10:20 AM
Management of Ph positive ALL
Robin Foà
Italy
10:20 AM - 10:40 AM
Novel Combination Therapies in Myelofibrosis
Naveen Pemmaraju
United States
10:40 AM - 11:00 AM
Q&A - Meet the Experts (S10)
Q&A - Meet the Experts
11:00 AM - 11:15 AM

Close

x

Thursday, January 01, 1970 at 12:00 AM - 12:00 AM on

Close

x
11:15 AM - 11:40 AM Industry Symposium by NovartisSTAMPing out CML

Industry Symposium by Novartis

Sunday, March 12, 2023 at 11:15 AM - 11:40 AM on

Chairperson :

Arif Alam
United Arab Emirates

Topics :

STAMPing out CML
Dennis Kim
Canada
11:15 AM - 11:40 AM

Close

x

Thursday, January 01, 1970 at 12:00 AM - 12:00 AM on

Close

x
11:40 AM - 12:00 PM Industry Symposium by AstraZeneca(Panel Discussion) - Covid 19 - evolution.. What have we learned so far - Does the new Normal apply to all?

Industry Symposium by AstraZeneca

Sunday, March 12, 2023 at 11:40 AM - 12:00 PM on

Chairperson :

Shahrukh Hashmi
United Arab Emirates
Jehad Abdalla
United Arab Emirates

Close

x

Thursday, January 01, 1970 at 12:00 AM - 12:00 AM on

Close

x
12:00 PM - 12:25 PM Industry Symposium by Sobi 2The use of TPO-RAs in ITP: Not all patients are the same

Industry Symposium by Sobi 2

Sunday, March 12, 2023 at 12:00 PM - 12:25 PM on

Chairperson :

Amar Lal
United Arab Emirates
Mahmoud Marashi
United Arab Emirates

Topics :

The use of TPO-RAs in ITP: Not all patients are the same
Drew Provan
12:00 PM - 12:25 PM

Close

x

Thursday, January 01, 1970 at 12:00 AM - 12:00 AM on

Close

x
12:25 PM - 12:50 PM Session 11AI in Hematology

Session 11

Sunday, March 12, 2023 at 12:25 PM - 12:50 PM on

Chairperson :

Muhammad Faisal Khanani
United Arab Emirates

Topics :

AI in Hematology
Shahrukh Hashmi
United Arab Emirates
12:25 PM - 12:50 PM

Close

x

Thursday, January 01, 1970 at 12:00 AM - 12:00 AM on

Close

x
12:50 PM - 02:30 PM Session 12: Myeloproliferative neoplasms

Session 12: Myeloproliferative neoplasms

Sunday, March 12, 2023 at 12:50 PM - 02:30 PM on

Chairperson :

Hasan Al Yaseen
United Arab Emirates
Mahmoud Marashi
United Arab Emirates

Topics :

WHO updates in MPN
Robert Hasserjian
United States
12:50 PM - 01:10 PM
How I treat MPN in 2023
Ayalew Tefferi
United States
01:10 PM - 01:55 PM
Management of MDS, is molecular targeting the way forward in the management?
Ayalew Tefferi
United States
01:55 PM - 02:15 PM
Q&A - Meet the Experts (S12)
Q&A - Meet the Experts
02:15 PM - 02:30 PM

Close

x

Thursday, January 01, 1970 at 12:00 AM - 12:00 AM on

Close

x
02:30 PM - 02:55 PM Industry Symposium by ServierHow to Treat IDH1 Mutant AML at Diagnosis and R/R Settings

Industry Symposium by Servier

Sunday, March 12, 2023 at 02:30 PM - 02:55 PM on

Chairperson :

Amar Lal
United Arab Emirates

Topics :

How to Treat IDH1 Mutant AML at Diagnosis and R/R Settings
Eytan Stein
02:30 PM - 02:55 PM

Close

x

Thursday, January 01, 1970 at 12:00 AM - 12:00 AM on

Close

x
02:30 PM - 05:00 PM

Thursday, January 01, 1970 at 12:00 AM - 12:00 AM on

Close

x
Workshop : Elevate the management of CLL

Workshop : Elevate the management of CLL

Sunday, March 12, 2023 at 02:30 PM - 05:00 PM on

Close

x
02:55 PM - 03:00 PM Closing Remarks
*The scientific program is subject to change.